Kinsenoside Suppresses DGAT1-Mediated Lipid Droplet Formation to Trigger Ferroptosis in Triple-Negative Breast Cancer

被引：0
作者：
Yang, Yaqin [1 ]
Chen, Dandan [1 ]
Zhu, Yuru [1 ]
Zhang, Min [1 ]
Zhao, Huajun [1 ,2 ]
机构：
[1] Zhejiang Chinese Med Univ, Sch Pharmaceut Sci, Hangzhou 311402, Peoples R China
[2] Zhejiang Chinese Med Univ, Acad Chinese Med Sci, Hangzhou 310053, Peoples R China
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2025年 / 26卷 / 05期
基金：
中国国家自然科学基金;
关键词：
kinsenoside; triple-negative breast cancer; ferroptosis; lipid droplet formation; DGAT1; ANOECTOCHILUS-ROXBURGHII; FATTY-ACIDS; ANTITUMOR; CELLS;
D O I：
10.3390/ijms26052322
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Triple-negative breast cancer (TNBC) presents limited therapeutic options and is characterized by a poor prognosis. Although Kinsenoside (KIN) possesses a wide range of pharmacological activities, its effect and mechanism in TNBC remain unclear. The objective of this research was to explore the therapeutic effectiveness and the molecular mechanisms of KIN on TNBC. Xenograft experiment was carried out to assess the impact of KIN on TNBC in vivo. The effect of KIN on TNBC in vitro was evaluated through the analysis of cell cytotoxicity and colony formation assays. Oil Red O staining and BODIPY 493/503 fluorescence staining were employed to detect the effect of KIN on lipid droplet (LD) formation. Transcriptomics and inhibitor-rescue experiments were conducted to investigate the role of KIN on TNBC. Mechanistic experiments, including quantitative real-time polymerase chain reaction (RT-qPCR), Western blotting, diacylglycerol acyltransferase 1 (DGAT1) overexpression assay, and flow cytometric assay, were employed to uncover the regulatory mechanisms of KIN on TNBC. KIN inhibited tumor growth without causing obvious toxicity to the liver and kidneys. In vitro experiments demonstrated that KIN significantly inhibited the viability and proliferation of TNBC cells, accompanied by decreased LD formation and lipid content. Polyunsaturated fatty acids (PUFAs) levels were significantly increased by KIN. Furthermore, transcriptomics and inhibitor-rescue experiments revealed that KIN induced ferroptosis in TNBC cells. KIN could significantly regulate ferroptosis-related proteins. Lipid peroxidation, iron accumulation, and GSH depletion also confirmed this. The LD inducer mitigated the KIN-induced ferroptosis in TNBC. The overexpression of DGAT1 attenuated the effects of KIN on cell viability and proliferation. Furthermore, the overexpression of DGAT1 inhibited the effect of KIN to trigger ferroptosis in TNBC cells. Our findings confirmed that KIN could trigger ferroptosis by suppressing DGAT1-mediated LD formation, thereby demonstrating a promising therapeutic effect of KIN in TNBC.
引用
收藏
页数：16
相关论文
共 38 条
  • [1] Bianchini G., De Angelis C., Licata L., Gianni L., Treatment landscape of triple-negative breast cancer—Expanded options, evolving needs, Nat. Rev. Clin. Oncol, 19, pp. 91-113, (2022)
  • [2] Bi G., Liang J., Bian Y., Shan G., Huang Y., Lu T., Zhang H., Jin X., Chen Z., Zhao M., Et al., Polyamine-mediated ferroptosis amplification acts as a targetable vulnerability in cancer, Nat. Commun, 15, (2024)
  • [3] Verma N., Vinik Y., Saroha A., Nair N.U., Ruppin E., Mills G., Karn T., Dubey V., Khera L., Raj H., Et al., Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis, Sci. Adv, 6, (2020)
  • [4] Li J., He D., Li S., Xiao J., Zhu Z., Ferroptosis: The emerging player in remodeling triple-negative breast cancer, Front. Immunol, 14, (2023)
  • [5] Snaebjornsson M.T., Janaki-Raman S., Schulze A., Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer, Cell Metab, 31, pp. 62-76, (2020)
  • [6] Martinez-Outschoorn U.E., Peiris-Pages M., Pestell R.G., Sotgia F., Lisanti M.P., Cancer metabolism: A therapeutic perspective, Nat. Rev. Clin. Oncol, 14, pp. 11-31, (2017)
  • [7] Olzmann J.A., Carvalho P., Dynamics and functions of lipid droplets, Nat. Rev. Mol. Cell Biol, 20, pp. 137-155, (2019)
  • [8] McLelland G.L., Lopez-Osias M., Verzijl C.R.C., Ellenbroek B.D., Oliveira R.A., Boon N.J., Dekker M., van den Hengel L.G., Ali R., Janssen H., Et al., Identification of an alternative triglyceride biosynthesis pathway, Nature, 621, pp. 171-178, (2023)
  • [9] Jarc E., Kump A., Malavasic P., Eichmann T.O., Zimmermann R., Petan T., Lipid droplets induced by secreted phospholipase A<sub>2</sub> and unsaturated fatty acids protect breast cancer cells from nutrient and lipotoxic stress, Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 1863, pp. 247-265, (2018)
  • [10] Lorito N., Subbiani A., Smiriglia A., Bacci M., Bonechi F., Tronci L., Romano E., Corrado A., Longo D.L., Iozzo M., Et al., FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer, EMBO Mol. Med, 16, pp. 1533-1559, (2024)
1234